China National Medicines Corporation Ltd. (SHA:600511)
China
· Delayed Price · Currency is CNY 28.70
-0.06 (-0.21%)
Apr 29, 2026, 11:05 AM CST
SHA:600511 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 53,263 | 52,421 | 50,500 | 49,592 | 45,436 | 46,442 | Upgrade
|
| Other Revenue | 47.56 | 47.56 | 97.79 | 103.99 | 62.95 | 26.26 | Upgrade
|
| Revenue | 53,311 | 52,468 | 50,597 | 49,696 | 45,499 | 46,469 | Upgrade
|
| Revenue Growth (YoY) | 4.15% | 3.70% | 1.81% | 9.22% | -2.09% | 15.08% | Upgrade
|
| Cost of Revenue | 49,832 | 49,014 | 47,003 | 45,704 | 41,681 | 42,848 | Upgrade
|
| Gross Profit | 3,478 | 3,454 | 3,594 | 3,992 | 3,817 | 3,621 | Upgrade
|
| Selling, General & Admin | 1,185 | 1,190 | 1,267 | 1,430 | 1,392 | 1,355 | Upgrade
|
| Research & Development | 68.26 | 69.31 | 73.71 | 71.2 | 67 | 55.75 | Upgrade
|
| Other Operating Expenses | 141.86 | 134.92 | 126.25 | 109.69 | 46.91 | 120.86 | Upgrade
|
| Operating Expenses | 1,429 | 1,428 | 1,489 | 1,620 | 1,498 | 1,566 | Upgrade
|
| Operating Income | 2,049 | 2,026 | 2,105 | 2,372 | 2,319 | 2,055 | Upgrade
|
| Interest Expense | -27.17 | -27.17 | -33.66 | -31.57 | -26.88 | -43.71 | Upgrade
|
| Interest & Investment Income | 635.74 | 622.87 | 620.95 | 525.32 | 362.42 | 354.09 | Upgrade
|
| Currency Exchange Gain (Loss) | -2.87 | -2.87 | 1.94 | 0.55 | -1.65 | 2.71 | Upgrade
|
| Other Non Operating Income (Expenses) | -41.36 | -4.18 | -7.04 | -9.23 | -43.29 | -18 | Upgrade
|
| EBT Excluding Unusual Items | 2,613 | 2,615 | 2,687 | 2,857 | 2,609 | 2,350 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.07 | 0.07 | -18.2 | 10.82 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.22 | 0.21 | -0.19 | 0.08 | 1.68 | -0.07 | Upgrade
|
| Other Unusual Items | -14.76 | -14.76 | -14.9 | 62.81 | 76.9 | 95.08 | Upgrade
|
| Pretax Income | 2,601 | 2,600 | 2,654 | 2,931 | 2,688 | 2,445 | Upgrade
|
| Income Tax Expense | 505.19 | 510.74 | 523.83 | 596.42 | 559.18 | 516.3 | Upgrade
|
| Earnings From Continuing Operations | 2,096 | 2,089 | 2,130 | 2,334 | 2,129 | 1,929 | Upgrade
|
| Minority Interest in Earnings | -84.02 | -92.81 | -129.65 | -188.47 | -164.65 | -174.42 | Upgrade
|
| Net Income | 2,012 | 1,997 | 2,000 | 2,146 | 1,964 | 1,754 | Upgrade
|
| Net Income to Common | 2,012 | 1,997 | 2,000 | 2,146 | 1,964 | 1,754 | Upgrade
|
| Net Income Growth | 0.61% | -0.18% | -6.80% | 9.26% | 11.97% | 26.86% | Upgrade
|
| Shares Outstanding (Basic) | 755 | 755 | 755 | 754 | 755 | 755 | Upgrade
|
| Shares Outstanding (Diluted) | 755 | 755 | 755 | 754 | 755 | 755 | Upgrade
|
| Shares Change (YoY) | 0.00% | 0.00% | 0.00% | -0.00% | - | 0.00% | Upgrade
|
| EPS (Basic) | 2.67 | 2.65 | 2.65 | 2.84 | 2.60 | 2.32 | Upgrade
|
| EPS (Diluted) | 2.67 | 2.65 | 2.65 | 2.84 | 2.60 | 2.32 | Upgrade
|
| EPS Growth | 0.60% | -0.18% | -6.80% | 9.27% | 11.97% | 26.86% | Upgrade
|
| Free Cash Flow | 238.48 | 1,937 | 1,528 | 2,582 | 2,265 | 1,862 | Upgrade
|
| Free Cash Flow Per Share | 0.32 | 2.57 | 2.03 | 3.42 | 3.00 | 2.47 | Upgrade
|
| Dividend Per Share | 0.800 | 0.800 | 0.800 | 0.854 | 0.782 | 0.700 | Upgrade
|
| Dividend Growth | - | - | -6.32% | 9.21% | 11.71% | 27.27% | Upgrade
|
| Gross Margin | 6.52% | 6.58% | 7.10% | 8.03% | 8.39% | 7.79% | Upgrade
|
| Operating Margin | 3.84% | 3.86% | 4.16% | 4.77% | 5.10% | 4.42% | Upgrade
|
| Profit Margin | 3.77% | 3.81% | 3.95% | 4.32% | 4.32% | 3.77% | Upgrade
|
| Free Cash Flow Margin | 0.45% | 3.69% | 3.02% | 5.20% | 4.98% | 4.01% | Upgrade
|
| EBITDA | 2,168 | 2,144 | 2,223 | 2,485 | 2,423 | 2,155 | Upgrade
|
| EBITDA Margin | 4.07% | 4.09% | 4.39% | 5.00% | 5.32% | 4.64% | Upgrade
|
| D&A For EBITDA | 118.45 | 118.49 | 118.63 | 113.09 | 103.86 | 100.1 | Upgrade
|
| EBIT | 2,049 | 2,026 | 2,105 | 2,372 | 2,319 | 2,055 | Upgrade
|
| EBIT Margin | 3.84% | 3.86% | 4.16% | 4.77% | 5.10% | 4.42% | Upgrade
|
| Effective Tax Rate | 19.42% | 19.64% | 19.74% | 20.35% | 20.80% | 21.12% | Upgrade
|
| Revenue as Reported | 52,468 | 52,468 | 50,597 | 49,696 | 45,499 | 46,469 | Upgrade
|
| Advertising Expenses | - | 2.91 | 4.74 | 6.7 | 3.25 | 2.25 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.